Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,243.00
Bid: 1,244.80
Ask: 1,245.80
Change: 18.80 (1.54%)
Spread: 1.00 (0.08%)
Open: 1,212.40
High: 1,247.00
Low: 1,210.80
Yest. Close: 1,224.20
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

BROKER RATINGS SUMMARY: Macquarie Starts Burberry At Outperform

19 Feb 16 09:36

LONDON BRIEFING: Coca-Cola HBC And Standard Life Impress With Results

19 Feb 16 08:21

LONDON MARKET CLOSE: Commodity, Ex-Dividend Stocks Weigh On FTSE 100

18 Feb 16 17:05

LONDON MARKET MIDDAY: NY Called Higher As Ex-Dividends Damp FTSE 100

18 Feb 16 12:19

WINNERS & LOSERS SUMMARY: Investors Warm To Centrica Results

18 Feb 16 10:34

LONDON MARKET OPEN: Ex-Dividends Weigh On FTSE 100 As Centrica Rises

18 Feb 16 08:34

Friday broker round-up

(ShareCast News) - Cambian Group: Berenberg downgrades to hold with a target of 60p. Shaftesbury: Credit Suisse upgrades to outperform with a target price of 945p. Acacia Mining: UBS and Deutsche Bank reiterate buy with a target of 275p and 280p respectively. Ashmore: Citigroup stays at buy with a

12 Feb 16 15:24

TOP NEWS SUMMARY: UK Regulator Fines GlaxoSmithKline GBP38 Million

12 Feb 16 11:06

UPDATE 2-UK watchdog fines GSK $54 mln over 'pay-for-delay' drug deals

* CMA says GSK delayed generic competition to Seroxat * GSK disagrees and considering grounds for appeal * Merck KGaA also fined as former parent of generic firm (Adds Merck comment) By Ben Hirschler LONDON, Feb 12 (Reuters) - Britain's competition watchdog has fined Gla

12 Feb 16 09:53

BROKER RATINGS SUMMARY: Investec Upgrades Standard Chartered To Buy

12 Feb 16 09:31

UPDATE 1-UK watchdog fines GSK $54 mln over 'pay-for-delay' drug deals

* CMA says GSK delayed generic competition to Seroxat * GSK strongly disagrees, considering grounds for appeal * Merck KGaA also fined as former parent of generic firm (Adds details on other companies and fines, context) By Ben Hirschler LONDON, Feb 12 (Reuters) - Britai

12 Feb 16 08:18

CMA fines GlaxoSmithKline £38m for generics delay scam

(ShareCast News) - The UK competition watchdog has fined GlaxoSmithKline for making illegal payments to rivals that delayed the launch of potentially cheaper generic medicine, potentially costing the NHS many millions. GSK has been fined £37.6m by the Competition and Markets Authority, with Merck fi

12 Feb 16 07:39

GlaxoSmithKline Fined As UK Competition Body Sends "Strong Message"

12 Feb 16 07:32

UK watchdog fines GSK $54 mln over 'pay-for-delay' drug deals

LONDON, Feb 12 (Reuters) - Britain's competition body said on Friday it had fined GlaxoSmithKline 37.6 million pounds ($54.42 million) for market abuse in striking deals to delay the launch of generic copies of its antidepressant Seroxat. GSK said it strongly disagreed and argued its action

12 Feb 16 07:18

Dividends Calendar - Week Ahead

11 Feb 16 16:06

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.